Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05961579
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-08
First Post:
2023-07-18
Brief Title:
Evaluating the Efficacy and Safety of Cleanser Serum and Sunscreen Products for Facial Redness
Sponsor:
Goldman Butterwick Fitzpatrick and Groff
Organization:
Goldman Butterwick Fitzpatrick and Groff
Study Overview
Official Title:
A Prospective Open Label Clinical Study Evaluating the Efficacy and Safety of Cleanser Serum and Sunscreen Products for the Treatment of Facial Redness
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to assess the efficacy and safety of combination therapy of a Barrier Renew Cleanser Barrier Renew PM Moisturizer and mineral sunscreen in the treatment of redness
Detailed Description:
Enrolled subjects will undergo treatment with Barrier Renew Cleanser Barrier Renew PM Moisturizer and mineral sunscreen Cleanser and Barrier Renew PM moisturizer will be used twice daily Mineral sunscreen will be used every morning and throughout the day as indicated
Subjects satisfying all inclusion and exclusion criteria will be enrolled in this trial Prior to receiving any study treatment mandatory photography using the VISIA system will be done Patients will return for follow-up assessments at week 2 4 and 8
Subjects satisfying all inclusion and exclusion criteria will be enrolled in this trial Prior to receiving any study treatment mandatory photography using the VISIA system will be done Patients will return for follow-up assessments at week 2 4 and 8
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None